Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discovery. Isogenica is developing LlamdA™ (single domain VHH) and Alexandria™ (human Fab) therapeutic antibodies based on its proprietary fully synthetic antibody libraries and leveraging its CIS Display and Colibra™ technologies to accelerate the discovery and development process.


BioProduction by Sekisui offers contract development and manufacturing services for the biopharmaceutical industry.  Our facility in the UK has over 40 years of fermentation and purification experience with enzymes and proteins as our focus.  We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, antibody fragments and other proteins.  We offer ISO 9001, ISO 13485 and GMP manufacturing quality standards for your custom production.  We are in the process of a $19M expansion of our GMP facility for drug substance manufacturing which will complete in 2023.